RFC
TCRT icon

Regions Financial Corp’s Alaunos Therapeutics TCRT Stock Holding History

Regions Financial Corp’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1
Closed -$1K – 1617
2019
Q1 		$1K Buy
+1
New +$418 ﹤0.01% 1884
2018
Q1 		– Sell
-3
Closed -$2K – 2089
2017
Q4 		$2K Buy
+3
New +$2.15K ﹤0.01% 1917

Other funds holding TCRT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Regions Financial Corp's TCRT Position: Q2 2019 in Review

Regions Financial Corp sold out of Alaunos Therapeutics (TCRT) in Q2 2019, closing a stake of 1 share — an estimated $1K sold.

Regions Financial Corp first reported a position in TCRT in Q4 2017 and held it in 2 quarters. The position peaked at $2K in Q4 2017. 140 funds tracked by Wall St. Rank hold TCRT as of Q2 2019.

  • Regions Financial Corp reported no remaining Alaunos Therapeutics position as of Q2 2019 after selling out during the quarter.
  • Regions Financial Corp sold 1 Alaunos Therapeutics share in Q2 2019, an estimated $1K.
  • Regions Financial Corp first reported a position in Alaunos Therapeutics in Q4 2017 and held it in 2 quarters.
  • Regions Financial Corp's Alaunos Therapeutics position peaked at $2K in Q4 2017.
  • 140 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q2 2019.

Based on Regions Financial Corp's 13F filing for Q2 2019, filed 19 Jul 2019.